What is Soligenix, Inc. (SNGX)?
Soligenix, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat rare diseases and unmet medical needs. The company's research and development efforts encompass areas such as biodefense, oncology, and inflammatory diseases. Soligenix utilizes proprietary technologies, including heat-stable formulations and novel delivery systems, to enhance the efficacy and stability of its therapeutic candidates. The company operates through various stages of clinical development, collaborating with government agencies and other partners to advance its pipeline. Its product portfolio includes vaccine candidates, therapeutics for gastrointestinal diseases, and treatments for cutaneous conditions. Soligenix's business model integrates innovation in biopharmaceutical science with strategic partnerships to address complex health challenges.
Soligenix, Inc. Stock Price Today: Live Overview
The price today is shaped by current intraday trading, as Soligenix, Inc. trades at $1.254. The price range today has spanned $1.176 to $1.246, marking a daily percentage change of 0%.
FAQ: Soligenix, Inc. (SNGX)
What is the current price of SNGX stock?
The current price is $1.254.
Does SNGX pay dividends?
The company does not pay dividends.
Does SNGX have a formal corporate presence or regional headquarters in the UAE?
Soligenix, Inc. does not have an official office or subsidiary in the UAE and operates through partners.
What is SNGX best known for?
The company is most famous for its development of biopharmaceuticals for rare diseases and biodefense.
What assets are typically shown together with SNGX?
Commonly shown alongside SNGX: Cyclerion Therapeutics, Inc., Schwab 1000 Index ETF, Empire Metals Ltd
Latest shares articles



